Down regulation of protein kinase C during growth enhancement induced by interleukin-6 on a human myeloma cell line, KMS-11

Cancer Letters

Volumn 107, Issue 1, 1996, Pages 131-136

  Shirato, Lisa ^a   Otsuki, Takemi ^a   Yamada, Osamu ^a   Namba, Masayoshi ^b   Nakajima, Hiroshi ^c   Nozawa, Yoshinori ^c   Ueki, Ayako ^a   Yawata, Yoshihito ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Interleukin 6; Multiple myeloma; Protein kinase C

Indexed keywords

INTERLEUKIN 6; PROTEIN KINASE C;

ADULT; AGED; ARTICLE; CASE REPORT; CELL MEMBRANE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSOL; ENZYME REPRESSION; FEMALE; HUMAN; HUMAN CELL; MALE; MYELOMA CELL; PRIORITY JOURNAL; PROTEIN TRANSPORT;

EID: 0030272702     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04381-9     Document Type: Article

References (20)

1. [1] Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Iwato, K., Asaoku, H., Tang, B., Tanabe, O., Tanaka, O., Kuramoto, A. and Kishimoto, T. (1988) Autocrine growth and requirement of BSF-2/IL-6 for human multiple myelomas, Nature, 332, 83-85.
2. [2] Anderson, K.C., Jones, R.M., Morimoto, C., Leavitt, P. and Barut, B.A. (1989) Response pattern of purified myeloma cells to hematopoietic growth factors, Blood, 73, 1915-1924.
3. [3] Klein, U., Zhang, X.-G., Jourdan, M., Content, J., Houssiau, F., Aarden, L., Piechaczyk, M. and Bataille, R. (1989) Paracrine rather than autocrìne regulation of myeloma-cell growth and differentiation by interleukin-6, Blood, 73, 517-526.
4. [4] Tanabe, O., Kawano, M., Tanaka, H., Iwato, K., Asaoku, H., Ishikawa, H., Nobuyoshi, M., Hirano, T., Kishimoto, T. and Kuramoto, A. (1989) BSF-2/IL-6 does not augment Ig secretion but stimulates proliferation in myeloma cells, Am. J. Hematol., 31, 258-262.
5. [5] Asaoku, H., Kawano, M., Iwato, K., Tanabe, O., Hirano, T., Kishimoto, T. and Kuramoto, A. (1988) Decrease in BSF-2/ IL-6 response in advanced cases of multiple myeloma, Blood, 72, 429-432.
6. [6] Zhang, X.-G., Klein, B. and Bataille, R. (1989) Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma, Blood, 74, 11-13.
7. [7] Bataille, R., Jourdan, M., Zhang, X.-G. and Klein, B. (1989) Serum levels of interleukin-6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias, J. Clin. Invest, 84, 2008-2011.
8. [8] Hata, H., Matsuzaki, H. and Takatsuki, K. (1990) Autocrine growth by two cytokines, interleukin-6 and tumor necrosis factor alpha, in the myeloma cell line KHM-1A, Acta Haematol., 83, 133-136.
9. [9] Jackson, N., Lowe, J., Ball, J., Bromidge, E., Ling, N.R., Larkins, S., Griffith, M.J. and Franklin, I.M. (1989) Two new IgA-λ plasma cell leukemia cell lines (JJN-1 and JJN-2) which proliferate in response to B cell stimulatory factor 2, Clin. Exp. Immunol., 75, 93-99.
10. [10] Shimizu, S., Yoshioka, R., Hirose, Y., Sugai, S., Tachibana, J. and Konda, S. (1989) Establishment of two interleukin 6 (B cell stimulatory factor 2/Interferon β)-dependent human bone marrow-derived myeloma cell lines, J. Exp. Med., 169, 339-344.
11. [11] Okuno, Y., Takahashi, T., Suzuki, A., Ichiba, S., Nakamura, K., Fukumoto, M., Okada, T., Okada, H. and Imura, H. (1991) Establishment and characterization of four myeloma cell lines which are responsive to interleukin-6 their growth, Leukemia, 5, 585-591.
12. [12] Castagna, M., Takai, Y., Kaibuchi, K., Sano, K., Kikkawa, U. and Nishizuka, Y. (1982) Direct activation of calcium-activated phospholipid dependent protein kinase by tumor-promoting phorbol esters, J. Biol. Chem., 257, 7874-7881.
13. [13] Nishizuka, Y. (1984) The role of protein kinase C in cell surface signal transduction and tumor promotion, Nature, 308, 723-729.
14. [14] Togawa, A., Inoue, N., Miyamoto, K., Hyodo, H. and Namba, M. (1982) Establishment and characterization of a human myeloma cell line (KMM-1), Int. J. Cancer, 29, 495-500.
15. [15] Ohtsuki, T., Yawata, Y., Wada, H., Sugihara, T., Mori, M. and Namba, M. (1989) Two human myeloma cell lines, amylase-producing KMS-12-PE and amylase-non-producing KMS-12-BM, were established from a patient, having the same chromosome marker, t(11;14)(q131q32), Br. J. Haematol., 73, 199-204.
16. [16] Namba, M., Ohtsuki, T., Mori, M., Togawa, A., Wada, H., Sugihara, T., Yawata, Y. and Kimoto, T. (1989) Establishment of five human myeloma cell lines, In Vitro Cell Dev. Biol., 25, 723-729.
17. [17] Hirano, T., Taga, T., Nakano, N., Yasukawa, K., Kashiwamura, S., Shimizu, K., Nakajima, K., Pyun, K.H. and Kishimoto, T. (1985) Purification to homogeneity and characterization of human B cell differentiation factor (BCDF or BSF-2), Proc. Natl. Acad. Sci. USA, 82, 5490-5494.
18. [18] Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S., Nakajima, K., Koyama, K., Iwamatsu, A., Tsunesawa, S., Sakiyama, F., Matsui, H., Takahara, Y., Taniguchi, T. and Kishimoto, T. (1986) Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin, Nature, 324, 73-76.
19. [19] Kikkawa, U., Takai, Y., Minakuchi, R., Inohara, S. and Nishizuka, Y. (1982) Calcium-activated, phospholipid-dependent protein kinase from rat brain: subcellular distribution, purification and properties, J. Biol. Chem., 257, 13341-13348.
20. 2+-dependent protein kinase in mast cells activated by various agonists, Biochem. Biophys. Res. Commun., 142, 645-653.